- $11.45bn
- $14.23bn
- $5.55bn
- 90
- 41
- 66
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,138 | 4,560 | 5,212 | 5,215 | 5,549 |
Cost of Revenue | |||||
Gross Profit | 3,812 | 3,185 | 3,705 | 3,705 | 3,922 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,323 | 4,265 | 4,552 | 4,773 | 5,130 |
Operating Profit | 815 | 295 | 660 | 442 | 419 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 743 | 246 | 586 | 235 | 290 |
Provision for Income Taxes | |||||
Net Income After Taxes | 600 | 448 | 524 | 223 | 263 |
Net Income Before Extraordinary Items | |||||
Net Income | 600 | 448 | 524 | 223 | 263 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 600 | 448 | 524 | 223 | 263 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.872 | 0.666 | 0.638 | 0.507 | 0.761 |
Dividends per Share |